CinCor Site 65 — Staten Island, New York

CinCor Site 65 is a clinical research site located in Staten Island, New York, United States 10305.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

CinCor Site 65 has participated in 1 clinical trials.

Therapeutic areas: Uncontrolled Hypertension.

Sponsors: CinCor Pharma, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CinCor Site 65?

CinCor Site 65 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CinCor Site 65 conducted?

CinCor Site 65 has 1 clinical trials on record. Their work covers Uncontrolled Hypertension.

Is CinCor Site 65 accredited by Crixeo Health?

CinCor Site 65 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CinCor Site 65?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.